Trading in Novo Nordisk shares by board members, executives and associated persons on 14 August 2018
Bagsværd, Denmark, 15 August 2018
- This document discloses the data of the transaction(s) made in Novo Nordisk shares by the company's board members, executives and their associated persons in accordance with Article 19 of Regulation No. 596/2014 on market abuse.
The company's board members, executives and their associated persons have given Novo Nordisk power of attorney on their behalf to publish trading in Novo Nordisk shares by the company's board members, executives and their associated persons.
|Katrine Sperling||+45 4442 email@example.com|
|Ken Inchausti (US)||+1 609 786 firstname.lastname@example.org|
|Peter Hugreffe Ankersen||+45 3075 email@example.com|
|Anders Mikkelsen||+45 3079 firstname.lastname@example.org|
|Valdemar Borum Svarrer||+45 3079 email@example.com|
Company announcement No 65 / 2018
This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Novo Nordisk A/S via GlobeNewswire